Caris director RSU tax withholding of 13,987 shrs
Caris Life Sciences director Brian J. Brille reported routine equity compensation-related activity involving company common stock.
Rhea-AI Filing Summary
Caris Life Sciences director Brian J. Brille reported routine equity compensation-related activity involving company common stock. On May 15, 2026, 13,987 shares of common stock were withheld at $15.25 per share to cover taxes on the vesting and settlement of RSUs, which is a tax-withholding disposition rather than an open-market sale.
After this tax withholding, Brille directly held 230,303 shares of common stock. In addition, a family trust held 500,000 shares of common stock, reflecting indirect ownership after previously separate family trusts were consolidated into a single trust. Brille disclaims beneficial ownership of these trust-held shares except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 13,987 | $15.25 | $213K |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Shares withheld for the payment of taxes on the vesting and settlement of RSUs.
- F2. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- F3. By a family trust, with shares previously held in multiple family trusts consolidated into a single trust.
Key Figures
Key Terms
RSUs financial
tax-withholding disposition financial
beneficial ownership financial
family trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Caris Life Sciences (CAI) director Brian J. Brille report on this Form 4?
What does the family trust holding mean for Caris Life Sciences (CAI) insider ownership?
AI-generated analysis. How Rhea-AI works. Not financial advice.